FDA recall, , Moderate risk
Oribe Serene Scalp Densifying Shampoo
Oribe Serene Scalp Densifying Shampoo may be contaminated with bacteria, posing infection risk to some people.
Summary by Recall Canary from the FDA notice
What happened
Kao USA Inc. issued a voluntary recall of select lots of its Oribe Serene Scalp Densifying Shampoo in the U.S. and Canada due to the detection of Pluralibacter gergoviae bacteria. The recall began June 9, 2026, and was announced July 1, 2026.
The product was distributed in Alaska, Alabama, Arkansas, Connecticut, Delaware, Florida, Georgia, Hawaii, Iowa, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Vermont, Wisconsin, West Virginia, the District of Columbia, and Canada.
The shampoo is packaged in 8.5 fl. oz. (250 mL) bottles and 33.8 fl. oz. (1 L) bottles.
What to do
If a code on your package is listed below:
- Regardless of health status, Kao USA is urging anyone who has affected products as specified below to discontinue use.
- To report any adverse events experienced with the use of this product, arrange for a replacement or for any questions, please contact the Kao Professional Hair Technical Hotline at 800-333-2442. Email oribecomplaints@
kao.com. - We are also asking retail and salon partners to remove affected lots from use and/or sale.
- Return them to us for safe disposal.
Is yours affected?
Match the UPC and lot code listed under your product.
A UPC is the number printed under a barcode.
Oribe Serene Scalp Densifying Shampoo 8.5 oz
- UPC
- 840035231242
- Lot code
- YR010556
- UPC
- 840035231273
- Lot code
- YR010566
- YR010576
Recall details
- Company began the recall
- Sold in
Alaska, Alabama, Arkansas, Connecticut, District of Columbia, Delaware, Florida, Georgia, Hawaii, Iowa, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maryland, Maine, Michigan, Minnesota, Missouri, Mississippi, North Carolina, New Hampshire, New Jersey, Nevada, New York, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia, Vermont, Wisconsin, West Virginia, and Canada
- Company
- KAO USA Inc
- Hazard
- Contamination
- Risk
Moderate risk
Using it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 99190
- Recall number
- C-0008-2026
- Quantity recalled
- 828 individual units
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA
Listed on Recall Canary
Announced by the company
In FDA's weekly enforcement report
Summary updated
